http://orcid.org/0000-0001-5147-5469
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cheryl A Gibson, Rebecca R Mount, Jaehoon Lee & James M Backes. (2022) Identifying Patient Perceptions and Attitudes Regarding statin-associated Diabetes Mellitus: A mixed-methods Study. Future Cardiology 18:10, pages 817-828.
Read now
Read now
Niki Katsiki, Kalliopi Kotsa, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2019) Statin use in patients with diabetes: one drug, multiple benefits. Expert Review of Cardiovascular Therapy 17:11, pages 839-840.
Read now
Read now
Articles from other publishers (18)
Jianan Ye, Keyu Guo, Jiaqi Li, Xia Li, Zhiguang Zhou & Lin Yang. (2024) Estimating the effect of lipid‐lowering agents on novel subtypes of adult‐onset diabetes. Diabetes/Metabolism Research and Reviews 40:4.
Crossref
Crossref
Alexios N. Matralis, Loukas Kaklamanis, Despina Perrea & Angeliki P. Kourounakis. (2023) Effect of a new squalene synthase inhibitor on an ApoE−/− mouse model of atherosclerosis. Bioorganic & Medicinal Chemistry 90, pages 117378.
Crossref
Crossref
Yulin Yang, Xiaolin Wang, Yongchao Wang, Hao Xu & Jian Li. (2023) SGLT2 inhibitors can reduce the incidence of abnormal blood glucose caused by statins in non-diabetes patients with HFrEF after PCI. BMC Cardiovascular Disorders 23:1.
Crossref
Crossref
Stanislava Rakusanova & Tomas Cajka. (2023) Current analytical methods to monitor type 2 diabetes medication in biological samples. TrAC Trends in Analytical Chemistry 158, pages 116831.
Crossref
Crossref
Enrica Rossini, Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Marcello Covino, Antonio Gasbarrini, Massimo Massetti & Andrea Flex. (2022) Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?. International Journal of Molecular Sciences 23:16, pages 9326.
Crossref
Crossref
Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi & Krishna Mohan Surapaneni. (2022) A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy. Clinics and Practice 12:4, pages 565-578.
Crossref
Crossref
V.A. Serhiyenko & A.A. Serhiyenko. (2022) Цукровий діабет, дисліпопротеїнемії та статини. Endokrynologia 27:1, pages 29-42.
Crossref
Crossref
Lijun WANG, Baihua ZHOU, Xinying LI, Yang WANG, Xiu Mei YANG, Hongwei WANG, Jun YAN & Jiakun DONG. (2022) The beneficial effects of exercise on glucose and lipid metabolism during statin therapy is partially mediated by changes of the intestinal flora. Bioscience of Microbiota, Food and Health 41:3, pages 112-120.
Crossref
Crossref
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús-González, Carlos Daniel Cordero-Rivera, Carlos Noe Farfan-Morales, Juan Fidel Osuna-Ramos, Gustavo Martínez-Mier, Judith Quistián-Galván, Armando Muñoz-Pérez, Víctor Bernal-Dolores, Rosa María del Ángel & José Manuel Reyes-Ruiz. (2021) Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. Frontiers in Immunology 12.
Crossref
Crossref
Lucie Dlouha, Terezie Pelikanova, Jiří Veleba, Vera Adamkova, Vera Lanska, Tomas Sosna, Lukas Pacal, Katerina Kankova & Jaroslav A. Hubacek. (2021) The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics. Molecular Biology Reports 48:8, pages 5873-5879.
Crossref
Crossref
Maria Nicol Arroyo, Jonathan Alex Green, Miriam Cnop & Mariana Igoillo-Esteve. (2021) tRNA Biology in the Pathogenesis of Diabetes: Role of Genetic and Environmental Factors. International Journal of Molecular Sciences 22:2, pages 496.
Crossref
Crossref
Manuel E. Machado-Duque, Diego Arturo Garcia, Melissa Hiromi Emura-Vélez, Andrés Gaviria-Mendoza & Jorge E. Machado-Alba. (2021) Prevalence of the Use of Aspirin and Statins for Preventing Cardiovascular Events in the Colombian Population with Type 2 Diabetes Mellitus: Comparison of 2008 and 2018. Journal of Primary Care & Community Health 12, pages 215013272110070.
Crossref
Crossref
Kevin C. Maki, Lane Benes & Mary R. Dicklin. 2021. Therapeutic Lipidology. Therapeutic Lipidology
307
322
.
Unai Galicia-Garcia, Shifa Jebari, Asier Larrea-Sebal, Kepa B. Uribe, Haziq Siddiqi, Helena Ostolaza, Asier Benito-Vicente & César Martín. (2020) Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights. International Journal of Molecular Sciences 21:13, pages 4725.
Crossref
Crossref
Beverley Bostock-Cox. (2020) Pre-diabetes and cardiovascular risk: detonating the time bomb. Practice Nursing 31:5, pages 200-205.
Crossref
Crossref
Girish A. Ghadge, Karthik Gourishetti, Mallikarjuna Rao Chamallamudi, Gopalan Kutty Nampurath, Krishnadas Nandakumar & Nitesh Kumar. (2020) Sesamol protects MIN6 pancreatic beta cells against simvastatin-induced toxicity by restoring mitochondrial membrane potentials. 3 Biotech 10:4.
Crossref
Crossref
Shah. (2019) Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review. Children 6:8, pages 89.
Crossref
Crossref
Yazhou HeXue LiDanijela GasevicEleanor BruntFiona McLachlanMarisa MillensonMaria TimofeevaJohn P.A. IoannidisHarry CampbellEvropi Theodoratou. (2018) Statins and Multiple Noncardiovascular Outcomes. Annals of Internal Medicine 169:8, pages 543.
Crossref
Crossref